亚临床动脉样硬化进展和回归的决定因素:一个时间视角
Rimsha Ahmad1, William H Frishman1, Wilbert S Aronow2
1From the Department of Internal Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.
Cardiology in review
|October 21, 2025
概括
早期识别亚临床动脉样硬化,心血管疾病的临床前阶段,是预防的关键. 了解其进展和回归驱动因素有助于向治疗和减少疾病负担.
科学领域:
- 心血管医学 心血管医学
- 预防性心脏病学 预防性心脏病学
- 生物标志物和成像技术
背景情况:
- 亚临床动脉样硬化在症状性动脉样硬化心血管疾病之前.
- 早期发现对于有效的初级预防策略至关重要.
- 识别斑块进展和回归的决定因素为治疗目标提供了信息.
研究的目的:
- 审查影响亚临床动脉样硬化进展和回归的因素的证据.
- 突出传统和新兴风险因素的作用.
- 讨论当前和新型成像生物标记物的实用性.
主要方法:
- 从大型队列,随机试验和元分析中综合证据.
- 对临床,生化,生活方式和成像数据的审查.
- 对斑块进展和回归的决定因素的分析.
主要成果:
- 传统的危险因素 (年龄,高血压,血脂不良,糖尿病,吸烟) 强烈预测进展.
- 新兴因素 (脂蛋白),炎症,代谢综合征,遗传学,压力) 是重要的调节因素.
- 图像工具 (CAC评分,CCT血管造影) 量化斑块;新型标记器提供预后见解.
- 通过强化治疗和生活方式改变,斑块回归是可能的.
结论:
- 了解亚临床动脉样硬化的多因素驱动因素对于初级预防至关重要.
- 需要对监测,治疗值和新生物标志物的进一步研究.
- 未来的方向包括纵向研究,用于个性化治疗的AI分析.
相关概念视频
Atherosclerosis I: Introduction
904
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
904
Inflammation
61.6K
Overview
61.6K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
458
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
458
Coronary Artery Disease II: Pathophysiology
366
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
366
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Coronary Artery Disease I: Introduction
876
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
876


